Related references
Note: Only part of the references are listed.Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review
Jayne L. Chamberlain et al.
JOURNAL OF NEUROLOGY (2021)
A Review of Complement Activation in SLE
Arthur Weinstein et al.
CURRENT RHEUMATOLOGY REPORTS (2021)
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome
Howard Trachtman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)
Global case studies for chronic kidney disease/end-stage kidney disease care
Chih-Wei Yang et al.
Kidney International Supplements (2020)
Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review
Kevin Yan et al.
CLINICAL EPIDEMIOLOGY (2020)
Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway
Marion Ort et al.
FRONTIERS IN IMMUNOLOGY (2020)
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance
Shuichi Ito et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2019)
Increase of Eosinophil in Dialysate During Induction of Peritoneal Dialysis
Emi Shigemoto et al.
PERITONEAL DIALYSIS INTERNATIONAL (2019)
Compendium of current complement therapeutics
Wioleta M. Zelek et al.
MOLECULAR IMMUNOLOGY (2019)
Expanding horizons in complement drug discovery: challenges and emerging strategies
Claire L. Harris
SEMINARS IN IMMUNOPATHOLOGY (2018)
C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy
Andrew S. Bomback et al.
KIDNEY INTERNATIONAL (2018)
Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease
Diana Jalal et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Developments in anti-complement therapy; from disease to clinical trial
Claire L. Harris et al.
MOLECULAR IMMUNOLOGY (2018)
Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology
Masashi Mizuno et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Timothy H. J. Goodship et al.
KIDNEY INTERNATIONAL (2017)
High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients
Masashi Mizuno et al.
PLOS ONE (2017)
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
Ikuto Masakane et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2015)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Simple sampling strategy for measuring inulin renal clearance
Masaru Horio et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2009)
Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study
Enyu Imai et al.
HYPERTENSION RESEARCH (2008)
A review of current knowledge of the complement system and the therapeutic opportunities in inflammatory arthritis
M. Mizuno
CURRENT MEDICINAL CHEMISTRY (2006)
Complement components as uremic toxins and their potential role as mediators of microinflammation
RM Deppisch et al.
KIDNEY INTERNATIONAL (2001)
The role of complement in the progression of renal fibrosis: a clinical study
S Matsuo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Share Paper
